CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Budapest, Hungary and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Budapest, Hungary and 82 other locations
The purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 w...
Phase 4
Budapest, Hungary and 39 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Budapest, Hungary and 119 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Budapest, Hungary and 140 other locations
The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...
Phase 3
Budapest, Hungary and 188 other locations
plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...
Phase 3
Budapest, Hungary and 40 other locations
This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma....
Phase 3
Budapest, Hungary and 23 other locations
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...
Phase 2
Budapest, Hungary and 175 other locations
The purpose of this study is to assess the efficacy and safety of of tafasitamab plus lenalidomide in adults with diffuse large B-cell lymphoma...
Phase 3
Budapest, Hungary and 60 other locations
Clinical trials
Research sites
Resources
Legal